NO137899C - Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamiderInfo
- Publication number
- NO137899C NO137899C NO2705/73A NO270573A NO137899C NO 137899 C NO137899 C NO 137899C NO 2705/73 A NO2705/73 A NO 2705/73A NO 270573 A NO270573 A NO 270573A NO 137899 C NO137899 C NO 137899C
- Authority
- NO
- Norway
- Prior art keywords
- damides
- kinal
- tetrazol
- preparation
- therapeutic active
- Prior art date
Links
- -1 1H-TETRAZOL-5-YL Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3099072A GB1383088A (en) | 1972-07-03 | 1972-07-03 | Pharmacologically active quinaldamide derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO137899B NO137899B (no) | 1978-02-06 |
NO137899C true NO137899C (no) | 1978-05-16 |
Family
ID=10316264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2705/73A NO137899C (no) | 1972-07-03 | 1973-07-02 | Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider |
Country Status (20)
Country | Link |
---|---|
US (1) | US3932416A (de) |
JP (1) | JPS4962486A (de) |
AT (1) | AT328449B (de) |
AU (1) | AU473752B2 (de) |
BE (1) | BE801246A (de) |
CH (1) | CH592081A5 (de) |
CS (1) | CS193474B2 (de) |
DE (1) | DE2332731A1 (de) |
ES (1) | ES416495A1 (de) |
FR (1) | FR2247241B1 (de) |
GB (1) | GB1383088A (de) |
HU (1) | HU168474B (de) |
IE (1) | IE37795B1 (de) |
IL (1) | IL42513A (de) |
LU (1) | LU67918A1 (de) |
NL (1) | NL7309226A (de) |
NO (1) | NO137899C (de) |
PH (1) | PH9997A (de) |
SE (1) | SE405477B (de) |
ZA (1) | ZA734041B (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1433774A (en) * | 1973-02-26 | 1976-04-28 | Allen & Hanburys Ltd | Heterocyclic compounds apparatus for conveying articles |
US4156726A (en) * | 1974-12-07 | 1979-05-29 | Fisons Limited | 4-Oxo-2-carboxyl quinoline derivatives used as antiallergic compounds |
US4186201A (en) * | 1977-02-07 | 1980-01-29 | Riker Laboratories, Inc. | Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds |
US4147694A (en) * | 1977-02-07 | 1979-04-03 | Riker Laboratories, Inc. | 8-(1H-Tetrazol-5-yl-carbamoyl)quinoline compounds |
US4474792A (en) * | 1979-06-18 | 1984-10-02 | Riker Laboratories, Inc. | N-Tetrazolyl benzamides and anti-allergic use thereof |
ZA811492B (en) * | 1980-03-05 | 1982-10-27 | Glaxo Group Ltd | Amidotetrazole compounds and processes for their preparation |
JPS61197558A (ja) * | 1985-02-25 | 1986-09-01 | Nippon Chemiphar Co Ltd | 新規なキナルジン酸アミド誘導体およびその製造法 |
US4772703A (en) * | 1986-01-27 | 1988-09-20 | American Home Products Corporation | 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents |
NZ234854A (en) * | 1989-08-11 | 1993-02-25 | Ici Plc | Quinoline derivatives, preparation, intermediates and pharmaceutical compositions thereof |
US5028707A (en) * | 1989-11-20 | 1991-07-02 | Board Of Regents, University Of Texas | 4-hydroxyquinaldic acid derivatives |
GB9010394D0 (en) * | 1990-05-09 | 1990-06-27 | Ici Plc | Heterocyclic compounds |
US6340704B1 (en) | 1997-04-25 | 2002-01-22 | Takeda Chemical Industries, Ltd. | Cell differentiation inducing amide derivatives, their production and use |
WO2001012608A1 (fr) * | 1999-08-18 | 2001-02-22 | Nippon Soda Co., Ltd. | Composes de quinoline et procede de preparation desdits composes |
FR2827599A1 (fr) * | 2001-07-20 | 2003-01-24 | Neuro3D | Composes derives de quinoleine et quinoxaline,preparation et utilisations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3391146A (en) * | 1964-11-10 | 1968-07-02 | Bristol Myers Co | Nu-substituted carbamates and thiocarbamates of 2-quinolinemethanols |
-
1972
- 1972-07-03 GB GB3099072A patent/GB1383088A/en not_active Expired
-
1973
- 1973-06-14 ZA ZA734041A patent/ZA734041B/xx unknown
- 1973-06-14 IE IE978/73A patent/IE37795B1/xx unknown
- 1973-06-15 IL IL42513A patent/IL42513A/en unknown
- 1973-06-18 CS CS734384A patent/CS193474B2/cs unknown
- 1973-06-19 AU AU57099/73A patent/AU473752B2/en not_active Expired
- 1973-06-21 HU HUAE386A patent/HU168474B/hu unknown
- 1973-06-21 BE BE132551A patent/BE801246A/xx unknown
- 1973-06-21 US US05/372,027 patent/US3932416A/en not_active Expired - Lifetime
- 1973-06-25 CH CH920573A patent/CH592081A5/xx not_active IP Right Cessation
- 1973-06-26 SE SE7309000A patent/SE405477B/xx unknown
- 1973-06-27 DE DE2332731A patent/DE2332731A1/de active Pending
- 1973-06-28 AT AT570873A patent/AT328449B/de not_active IP Right Cessation
- 1973-07-02 ES ES416495A patent/ES416495A1/es not_active Expired
- 1973-07-02 NO NO2705/73A patent/NO137899C/no unknown
- 1973-07-02 LU LU67918A patent/LU67918A1/xx unknown
- 1973-07-02 PH PH14792A patent/PH9997A/en unknown
- 1973-07-03 JP JP48075190A patent/JPS4962486A/ja active Pending
- 1973-07-03 NL NL7309226A patent/NL7309226A/xx not_active Application Discontinuation
- 1973-07-03 FR FR7324350A patent/FR2247241B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CH592081A5 (de) | 1977-10-14 |
PH9997A (en) | 1976-07-13 |
BE801246A (fr) | 1973-12-21 |
IL42513A0 (en) | 1973-08-29 |
LU67918A1 (de) | 1973-09-05 |
NL7309226A (de) | 1974-01-07 |
IE37795B1 (en) | 1977-10-12 |
IE37795L (en) | 1974-01-03 |
CS193474B2 (en) | 1979-10-31 |
ZA734041B (en) | 1974-05-29 |
FR2247241B1 (de) | 1976-12-31 |
US3932416A (en) | 1976-01-13 |
SE405477B (sv) | 1978-12-11 |
AU473752B2 (en) | 1976-07-01 |
IL42513A (en) | 1976-12-31 |
HU168474B (de) | 1976-05-28 |
NO137899B (no) | 1978-02-06 |
FR2247241A1 (de) | 1975-05-09 |
JPS4962486A (de) | 1974-06-17 |
DE2332731A1 (de) | 1974-03-07 |
GB1383088A (en) | 1975-02-05 |
AU5709973A (en) | 1974-12-19 |
ATA570873A (de) | 1975-06-15 |
AT328449B (de) | 1976-03-25 |
ES416495A1 (es) | 1976-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO138807C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivr e 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporine | |
NO140381C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner | |
NO138335C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer | |
NO793013L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater | |
NO139560C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater | |
NO138566C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater | |
NO137694C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner | |
NO143575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater | |
NO145056C (no) | (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater | |
NO140058C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater | |
NO137899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider | |
NO139685C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater | |
NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
NO140977C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner | |
NO137824C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkyltetrazoler | |
NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
NO140670C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater | |
SE400551B (sv) | Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat | |
NO139088C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner | |
NO138063C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater | |
NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
NO137728C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater | |
NO138026C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner | |
NO139050C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater | |
NO138251C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer |